TrialBlood2015
Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use.
Marilyn J Telen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
112 papers cite itlatest 60 shown
this paperpooled ittrialcites it